drugset / Trial / NCT03712163
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a Phase 1, single-center, double-blind, randomized, placebo-controlled, 2-part, single ascending dose and multiple dose cohort study of orally administered Norketotifen (NKT) in healthy subjects.
Timeline
- Start
- 2018-10-15
- Primary completion
- 2019-02-18
- Completion
- 2019-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norketotifen | Small molecule | — | Oral |
Indications
No indication recorded.